Annual EBITDA
-$240.49 M
-$71.21 M-42.07%
31 December 2023
Summary:
Dyne Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$240.49 million, with the most recent change of -$71.21 million (-42.07%) on 31 December 2023. During the last 3 years, it has fallen by -$182.15 million (-312.21%). DYN annual EBITDA is now -4923.79% below its all-time high of -$4.79 million, reached on 31 December 2018.DYN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$105.22 M
-$33.66 M-47.03%
30 September 2024
Summary:
Dyne Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$105.22 million, with the most recent change of -$33.66 million (-47.03%) on 30 September 2024. Over the past year, it has dropped by -$43.38 million (-70.14%). DYN quarterly EBITDA is now -1901.54% below its all-time high of -$5.26 million, reached on 31 December 2019.DYN Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$312.84 M
-$43.38 M-16.10%
30 September 2024
Summary:
Dyne Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$312.84 million, with the most recent change of -$43.38 million (-16.10%) on 30 September 2024. Over the past year, it has dropped by -$99.90 million (-46.91%). DYN TTM EBITDA is now -5323.79% below its all-time high of -$5.77 million, reached on 30 September 2019.DYN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.1% | -70.1% | -46.9% |
| 3 y3 years | -312.2% | -147.5% | -148.9% |
| 5 y5 years | -4923.8% | -1724.2% | -5323.8% |
DYN EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -312.2% | at low | -197.6% | at low | -148.9% | at low |
| 5 y | 5 years | -4923.8% | at low | -1901.5% | at low | -5323.8% | at low |
| alltime | all time | -4923.8% | at low | -1901.5% | at low | -5323.8% | at low |
Dyne Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$105.22 M(+47.0%) | -$312.84 M(+16.1%) |
| June 2024 | - | -$71.56 M(+4.1%) | -$269.46 M(+2.0%) |
| Mar 2024 | - | -$68.77 M(+2.2%) | -$264.21 M(+9.9%) |
| Dec 2023 | -$240.49 M(+42.1%) | -$67.29 M(+8.8%) | -$240.49 M(+12.9%) |
| Sept 2023 | - | -$61.84 M(-6.7%) | -$212.94 M(+10.3%) |
| June 2023 | - | -$66.31 M(+47.2%) | -$192.98 M(+7.8%) |
| Mar 2023 | - | -$45.05 M(+13.4%) | -$178.97 M(+5.7%) |
| Dec 2022 | -$169.28 M(+13.7%) | -$39.74 M(-5.1%) | -$169.28 M(-6.6%) |
| Sept 2022 | - | -$41.88 M(-19.9%) | -$181.15 M(-0.3%) |
| June 2022 | - | -$52.30 M(+47.9%) | -$181.78 M(+14.0%) |
| Mar 2022 | - | -$35.36 M(-31.5%) | -$159.40 M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$148.94 M(+155.3%) | -$51.62 M(+21.4%) | -$148.94 M(+18.5%) |
| Sept 2021 | - | -$42.51 M(+42.1%) | -$125.67 M(+29.9%) |
| June 2021 | - | -$29.92 M(+20.2%) | -$96.78 M(+28.1%) |
| Mar 2021 | - | -$24.90 M(-12.2%) | -$75.56 M(+29.5%) |
| Dec 2020 | -$58.34 M(+299.9%) | -$28.35 M(+108.2%) | -$58.34 M(+65.5%) |
| Sept 2020 | - | -$13.62 M(+56.5%) | -$35.25 M(+28.6%) |
| June 2020 | - | -$8.70 M(+13.3%) | -$27.40 M(+46.5%) |
| Mar 2020 | - | -$7.68 M(+46.1%) | -$18.70 M(+69.7%) |
| Dec 2019 | -$14.59 M(+204.7%) | -$5.26 M(-8.9%) | -$11.03 M(+91.1%) |
| Sept 2019 | - | -$5.77 M | -$5.77 M |
| Dec 2018 | -$4.79 M | - | - |
FAQ
- What is Dyne Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics annual EBITDA year-on-year change?
- What is Dyne Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly EBITDA year-on-year change?
- What is Dyne Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Dyne Therapeutics?
- What is Dyne Therapeutics TTM EBITDA year-on-year change?
What is Dyne Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of DYN is -$240.49 M
What is the all time high annual EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$4.79 M
What is Dyne Therapeutics annual EBITDA year-on-year change?
Over the past year, DYN annual earnings before interest, taxes, depreciation & amortization has changed by -$71.21 M (-42.07%)
What is Dyne Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of DYN is -$105.22 M
What is the all time high quarterly EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$5.26 M
What is Dyne Therapeutics quarterly EBITDA year-on-year change?
Over the past year, DYN quarterly earnings before interest, taxes, depreciation & amortization has changed by -$43.38 M (-70.14%)
What is Dyne Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of DYN is -$312.84 M
What is the all time high TTM EBITDA for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$5.77 M
What is Dyne Therapeutics TTM EBITDA year-on-year change?
Over the past year, DYN TTM earnings before interest, taxes, depreciation & amortization has changed by -$99.90 M (-46.91%)